Publications by authors named "Rawand Naser"
Background: The COVID-19 outbreak has led to the rapid development and administration of the COVID-19 vaccines worldwide. Data about the immunogenicity and adverse effects of the vaccine on patients with systemic autoimmune rheumatic diseases (SARDs) is emerging.
Aim: To evaluate Pfizer/BioNTech (BNT162b2) mRNA-based vaccine second-dose immunogenicity and safety, and the relation between them, in patients with SARDs.
Article Synopsis
- The study examined the effectiveness of a modified CHADS-VASc score (M-RCHADS-VASc) that includes kidney function and male sex in predicting mortality risk for COVID-19 patients.
- Conducted with 800 hospitalized adults, results showed 30-day mortality rates increased with higher M-RCHADS-VASc categories: 4.7% in low risk, 17% in intermediate, and 31% in high risk.
- The M-RCHADS-VASc score proved useful in assessing patient outcomes, also correlating with higher needs for interventions like mechanical ventilation and kidney support.
Introduction: While there is evidence of the presence of the coronavirus in the kidneys and resultant acute kidney injury (AKI), information on the effect of chronic kidney disease (CKD) on COVID-19 outcomes and its pathogenesis is currently lacking.
Methods: This retrospective, observational study evaluated the outcomes of all consecutive patients hospitalized during COVID-19 outbreaks in Meir Medical Center. Serum creatinine level was assessed before hospitalization ("baseline serum creatinine") and at admission, as well as minimum and maximum serum creatinine levels during hospitalization.